243 related articles for article (PubMed ID: 34354203)
1. Role of structural specificity of ZnO particles in preserving functionality of proteins in their corona.
Singh U; Saifi Z; Kumar M; Reimers A; Krishnananda SD; Adelung R; Baum M
Sci Rep; 2021 Aug; 11(1):15945. PubMed ID: 34354203
[TBL] [Abstract][Full Text] [Related]
2. Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System.
Srivastav AK; Dhiman N; Khan H; Srivastav AK; Yadav SK; Prakash J; Arjaria N; Singh D; Yadav S; Patnaik S; Kumar M
J Pharm Sci; 2019 May; 108(5):1872-1889. PubMed ID: 30615879
[TBL] [Abstract][Full Text] [Related]
3. Intentional formation of a protein corona on nanoparticles: Serum concentration affects protein corona mass, surface charge, and nanoparticle-cell interaction.
Gräfe C; Weidner A; Lühe MV; Bergemann C; Schacher FH; Clement JH; Dutz S
Int J Biochem Cell Biol; 2016 Jun; 75():196-202. PubMed ID: 26556312
[TBL] [Abstract][Full Text] [Related]
4. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
5. A health concern regarding the protein corona, aggregation and disaggregation.
Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
[TBL] [Abstract][Full Text] [Related]
6. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
Park SJ
Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of zinc oxide nanoparticles with amorphous silica alters their fate in the circulation.
Konduru NV; Murdaugh KM; Swami A; Jimenez RJ; Donaghey TC; Demokritou P; Brain JD; Molina RM
Nanotoxicology; 2016 Aug; 10(6):720-7. PubMed ID: 26581431
[TBL] [Abstract][Full Text] [Related]
8. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
[TBL] [Abstract][Full Text] [Related]
9. Protein-corona formation on aluminum doped zinc oxide and gallium nitride nanoparticles.
Ciobanu V; Roncari F; Ceccone G; Braniste T; Ponti J; Bogni A; Guerrini G; Cassano D; Colpo P; Tiginyanu I
J Appl Biomater Funct Mater; 2022; 20():22808000221131881. PubMed ID: 36254110
[TBL] [Abstract][Full Text] [Related]
10. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
[TBL] [Abstract][Full Text] [Related]
11. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
Ahsan SM; Rao CM; Ahmad MF
Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
[TBL] [Abstract][Full Text] [Related]
13. Polymer-coated nanoparticle protein corona formation potentiates phagocytosis of bacteria by innate immune cells and inhibits coagulation in human plasma.
Ortega VA; Bahniuk MS; Memon S; Unsworth LD; Stafford JL; Goss GG
Biointerphases; 2020 Sep; 15(5):051003. PubMed ID: 32957792
[TBL] [Abstract][Full Text] [Related]
14. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
Kharazian B; Hadipour NL; Ejtehadi MR
Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
[TBL] [Abstract][Full Text] [Related]
15. Promising insights into the kosmotropic effect of magnetic nanoparticles on proteins: The pivotal role of protein corona formation.
Fattah R; Rashedi H; Yazdian F; Mousavi SB; Fazeli A
Biotechnol Prog; 2020 Nov; 36(6):e3051. PubMed ID: 32692433
[TBL] [Abstract][Full Text] [Related]
16. Research progress and application opportunities of nanoparticle-protein corona complexes.
Huang W; Xiao G; Zhang Y; Min W
Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
[TBL] [Abstract][Full Text] [Related]
17. Protein corona: implications for nanoparticle interactions with pulmonary cells.
Konduru NV; Molina RM; Swami A; Damiani F; Pyrgiotakis G; Lin P; Andreozzi P; Donaghey TC; Demokritou P; Krol S; Kreyling W; Brain JD
Part Fibre Toxicol; 2017 Oct; 14(1):42. PubMed ID: 29084556
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.
Saha K; Rahimi M; Yazdani M; Kim ST; Moyano DF; Hou S; Das R; Mout R; Rezaee F; Mahmoudi M; Rotello VM
ACS Nano; 2016 Apr; 10(4):4421-30. PubMed ID: 27040442
[TBL] [Abstract][Full Text] [Related]
19. Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.
Portilla Y; Mellid S; Paradela A; Ramos-Fernández A; Daviu N; Sanz-Ortega L; Pérez-Yagüe S; Morales MP; Barber DF
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7924-7944. PubMed ID: 33587585
[TBL] [Abstract][Full Text] [Related]
20. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
Randhawa S; Abidi SMS; Dar AI; Acharya A
Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
